Core Laboratories N.V. (CLB) — Analyst outlook / Analyst consensus target is. Based on 37 analyst ratings, the consensus is bullish — 16 Buy, 17 Hold, 4 Sell.
The consensus price target is $25.00 (low: $17.00, high: $32.00), representing an upside of 53.7% from the current price $16.27.
Analysts estimate Earnings Per Share (EPS) of $0.88 and revenue of $0.53B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.67 vs est $0.88 (missed -24%). 2025: actual $0.68 vs est $0.74 (missed -7.9%). Analyst accuracy: 80%.
CLB Stock — 12-Month Price Forecast
$25.00
▲ +53.66% Upside
Average Price Target
Based on 37 Wall Street analysts offering 12-month price targets for Core Laboratories N.V., the average price target is $25.00, with a high forecast of $32.00, and a low forecast of $17.00.
The average price target represents a +53.66% change from the last price of $16.27.
Highest Price Target
$32.00
Average Price Target
$25.00
Lowest Price Target
$17.00
CLB Analyst Ratings
Hold
Based on 37 analysts giving stock ratings to Core Laboratories N.V. in the past 3 months
EPS Estimates — CLB
80%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.67
vs Est $0.88
▼ 31.5% off
2025
Actual $0.68
vs Est $0.74
▼ 8.6% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — CLB
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.524B
vs Est $0.527B
▼ 0.6% off
2025
Actual $0.527B
vs Est $0.520B
▲ 1.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
